SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids

Virology

Volumn 379, Issue 1, 2008, Pages 110-117

  Nakanishi, Akira ^a   Chapellier, Benoit ^a   Maekawa, Naoya ^a   Hiramoto, Masaki ^a   Kuge, Takeshi ^a   Takahashi, Ryo u ^b   Handa, Hiroshi ^b   Imai, Takeshi ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Capsid function; Gene targeting; Polyomavirus; Viral vector

Indexed keywords

CAPSID PROTEIN; VIRUS ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BK VIRUS; CELL TYPE; DNA SEQUENCE; DNA TRANSFECTION; GENE CASSETTE; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; JC VIRUS; METHODOLOGY; NONHUMAN; PAPOVAVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIMIAN VIRUS 40; TARGET CELL; VIRION; VIRUS CAPSID;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; BK VIRUS; CAPSID PROTEINS; GENES, REPORTER; GENETIC VECTORS; JC VIRUS; REPLICATION ORIGIN; SIMIAN VIRUS 40; TRANSDUCTION, GENETIC; VIROLOGY;

AFRICAN GREEN MONKEY POLYOMAVIRUS; BK POLYOMAVIRUS; JC POLYOMAVIRUS; MIRIDAE; POLYOMAVIRUS; SIMIAN VIRUS 40;

EID: 48949099695     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.06.032     Document Type: Article

References (44)

1. Allander T., Andreasson K., Gupta S., Bjerkner A., Bogdanovic G., Persson M.A., Dalianis T., Ramqvist T., and Andersson B. Identification of a third human polyomavirus. J Virol 81 8 (2007) 4130-4136
2. Arad U., Ben-Nun-Shaul O., El-Latif M.A., Nissim O., and Oppenheim A. A new packaging cell line for SV40 vectors that eliminates the generation of T-antigen-positive, replication-competent recombinants. Virology 304 2 (2002) 155-159
3. Assouline J.G., and Major E.O. Human fetal Schwann cells support JC virus multiplication. J Virol 65 2 (1991) 1002-1006
4. Brade L., Vogl W., Gissman L., and zur Hausen H. Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA. Virology 114 1 (1981) 228-235
5. Buck C.B., Pastrana D.V., Lowy D.R., and Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J Virol 78 2 (2004) 751-757
6. Chang X.B., and Wilson J.H. Formation of deletions after initiation of simian virus 40 replication: influence of packaging limit of the capsid. J Virol 58 2 (1986) 393-401
7. Chen B.J., and Atwood W.J. Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism. Virology 300 2 (2002) 282-290
8. Fang B., Koch P., Bouvet M., Ji L., and Roth J.A. A packaging system for SV40 vectors without viral coding sequences. Anal Biochem 254 1 (1997) 139-143
9. Feng H., Shuda M., Chang Y., and Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 1152586
10. Gaynor A.M., Nissen M.D., Whiley D.M., Mackay I.M., Lambert S.B., Wu G., Brennan D.C., Storch G.A., Sloots T.P., and Wang D. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3 5 (2007) e64
11. Gregorevic P., Blankinship M.J., Allen J.M., Crawford R.W., Meuse L., Miller D.G., Russell D.W., and Chamberlain J.S. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10 8 (2004) 828-834
12. Grimm D., and Kay M.A. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 3 4 (2003) 281-304
13. Haun G., Keppler O.T., Bock C.T., Herrmann M., Zentgraf H., and Pawlita M. The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus. J Virol 67 12 (1993) 7482-7492
14. Herrmann M., Oppenlander M., and Pawlita M. Fast and high-affinity binding of B-lymphotropic papovavirus to human B-lymphoma cell lines. J Virol 69 11 (1995) 6797-6804
15. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., and Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77 1 (1989) 51-59
16. Howley P.M., Rentier-Delrue F., Heilman C.A., Law M.F., Chowdhury K., Israel M.A., and Takemoto K.K. Cloned human polyomavirus JC DNA can transform human amnion cells. J Virol 36 3 (1980) 878-882
17. Imperiale M.J., and Major E.O. In: Knipe D.M., and Howley P.M. (Eds). "Polyomaviruses." 5 ed. Field's Virology (2007), Lipppincott Williams & Wilkins, Philadelohia, PA 19106 USA
18. Ishii N., Nakanishi A., Yamada M., Macalalad M.H., and Kasamatsu H. Functional complementation of nuclear targeting-defective mutants of simian virus 40 structural proteins. J Virol 68 12 (1994) 8209-8216
19. Ishizu K.I., Watanabe H., Han S.I., Kanesashi S.N., Hoque M., Yajima H., Kataoka K., and Handa H. Roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein. J Virol 75 1 (2001) 61-72
20. Kimchi-Sarfaty C., Arora M., Sandalon Z., Oppenheim A., and Gottesman M.M. High cloning capacity of in vitro packaged SV40 vectors with no SV40 virus sequences. Hum Gene Ther 14 2 (2003) 167-177
21. Kimchi-Sarfaty C., Ben-Nun-Shaul O., Rund D., Oppenheim A., and Gottesman M.M. In vitro-packaged SV40 pseudovirions as highly efficient vectors for gene transfer. Hum Gene Ther 13 2 (2002) 299-310
22. Li P.P., Naknanishi A., Tran M.A., Ishizu K., Kawano M., Phillips M., Handa H., Liddington R.C., and Kasamatsu H. Importance of Vp1 calcium-binding residues in assembly, cell entry, and nuclear entry of simian virus 40. J Virol 77 13 (2003) 7527-7538
23. Major E.O., Amemiya K., Elder G., and Houff S.A. Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J Neurosci Res 27 4 (1990) 461-471
24. Major E.O., Miller A.E., Mourrain P., Traub R.G., de Widt E., and Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U S A 82 4 (1985) 1257-1261
25. Major E.O., and Vacante D.A. Human fetal astrocytes in culture support the growth of the neurotropic human polyomavirus, JCV. J Neuropathol Exp Neurol 48 4 (1989) 425-436
26. Nakai H., Fuess S., Storm T.A., Muramatsu S., Nara Y., and Kay M.A. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J Virol 79 1 (2005) 214-224
27. Nakanishi A., Shum D., Morioka H., Otsuka E., and Kasamatsu H. Interaction of the Vp3 nuclear localization signal with the importin alpha 2/beta heterodimer directs nuclear entry of infecting simian virus 40. J Virol 76 18 (2002) 9368-9377
28. Nishimoto Y., Takasaka T., Hasegawa M., Zheng H.Y., Chen Q., Sugimoto C., Kitamura T., and Yogo Y. Evolution of BK virus based on complete genome data. J Mol Evol 63 3 (2006) 341-352
29. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 2 (1991) 193-199
30. Oppenheim A., and Peleg A. Helpers for efficient encapsidation of SV40 pseudovirions. Gene 77 1 (1989) 79-86
31. Oppenheim A., Sandalon Z., Peleg A., Shaul O., Nicolis S., and Ottolenghi S. A cis-acting DNA signal for encapsidation of simian virus 40. J Virol 66 9 (1992) 5320-5328
32. Reddy V.B., Thimmappaya B., Dhar R., Subramanian K.N., Zain B.S., Pan J., Ghosh P.K., Celma M.L., and Weissman S.M. The genome of simian virus 40. Science 200 4341 (1978) 494-502
33. Shayakhmetov D.M., Carlson C.A., Stecher H., Li Q., Stamatoyannopoulos G., and Lieber A. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells. J Virol 76 3 (2002) 1135-1143
34. Shishido-Hara Y., Ichinose S., Higuchi K., Hara Y., and Yasui K. Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions. J Virol 78 18 (2004) 9890-9903
35. Stecher H., Shayakhmetov D.M., Stamatoyannopoulos G., and Lieber A. A capsid-modified adenovirus vector devoid of all viral genes: assessment of transduction and toxicity in human hematopoietic cells. Mol Ther 4 1 (2001) 36-44
36. Strayer D.S. SV40 as an effective gene transfer vector in vivo. J Biol Chem 271 40 (1996) 24741-24746
37. Strayer D.S., and Milano J. SV40 mediates stable gene transfer in vivo. Gene Ther 3 7 (1996) 581-587
38. Strayer D.S., Zern M.A., and Chowdhury J.R. What can SV40-derived vectors do for gene therapy?. Curr Opin Mol Ther 4 4 (2002) 313-323
39. Takebe Y., Seiki M., Fujisawa J., Hoy P., Yokota K., Arai K., Yoshida M., and Arai N. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 8 1 (1988) 466-472
40. Takemoto K.K., Furuno A., Kato K., and Yoshiike K. Biological and biochemical studies of African green monkey lymphotropic papovavirus. J Virol 42 2 (1982) 502-509
41. Takemoto K.K., Linke H., Miyamura T., and Fareed G.C. Persistent BK papovavirus infection of transformed human fetal brain cells. I. Episomal viral DNA in cloned lines deficient in T-antigen expression. J Virol 29 3 (1979) 1177-1185
42. Vera M., and Fortes P. Simian virus-40 as a gene therapy vector. DNA Cell Biol 23 5 (2004) 271-282
43. Vera M., Prieto J., Strayer D.S., and Fortes P. Factors influencing the production of recombinant SV40 vectors. Mol Ther 10 4 (2004) 780-791
44. Wei G., Liu C.K., and Atwood W.J. JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes. J Neurovirol 6 2 (2000) 127-136